Ontology highlight
ABSTRACT: Background
Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored. Previous findings suggest that tumour infiltrating lymphocytes and immune-related gene expression may be altered by treatment with aromatase inhibitors. However, whether these changes are a direct result of impacts on the host immune system or mediated through tumour cells is not known. We aimed to investigate the effect of oestrogen deprivation on the expression of chemokines and immune infiltration in vitro and in an ER+ immunocompetent mouse model.Methods
RT-qPCR and a bead-based Bioplex system wer
SUBMITTER: Hazlett J
PROVIDER: S-EPMC8489094 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature